General Information
- Experiment ID
- OEX022985
- Experiment Name
- OEX_Jiexian_2304021031
- Experiment Type
- Transcriptomic
- Description
- To begin to elucidate the mechanism of action of decitabine with etoposide-based(D+E) treatment, we selected the TP53 mutation (THP-1 and U937) and TP53 WT (MOLM13 and OCI ) AML/MDS cell lines and treated them with etoposide and decitabine according to the indicated dose
Experiment information
- Attributes
-
library_layout Paired mate_pair n/a insertion_size n/a number_of_reads_sequenced n/a library_name n/a library_selection RANDOM library_strategy RNA-Seq platform Illumina HiSeq 2000 - Project
-
1
Project ID Project name Create Date OEP004090 Combination of decitabine and epitoside is highly effective in treating p53-mutated MDS/AMLmds via activating notch signaling 2023-04-01 - Samples
-
1
Sample ID Sample Name Organism Tissue Create Date OES304208 THP-1/U937/MOLM13/OCI treated(or untreated) with etoposide and decitabine Homo sapiens blood cell line 2023-04-02 - Runs
-
1
Run ID Run Name Sample Data Num Create Date OER393409 OER_Jiexian_2304021039 THP-1/U937/MOLM13/OCI treated(or untreated) with etoposide and decitabine 48 2023-04-02
Author Information
- Create Date
- 2023-04-02
- Last Modified
- 2023-04-02
- Submission
- Jiexian Ma
- Fudan university